Mp03-12 Staging Advanced and Metastatic Clear Cell Renal Cell Carcinoma With 68 Gallium Psma Pet for Treatment Planning

PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy

“…Notably, two (40%) of these patients had additional foci of radiotracer uptake (a total of 11 sites) that were suspicious for sites of metastases but lacked corresponding findings on conventional imaging. Similar results have since been reported using a gallium 68-labeled radiotracer targeting PSMA [7,8]. Combined, these data support a potential role for PSMA-targeted PET/CT to detect sites of otherwise clinically occult metastatic ccRCC.…”